Last news
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...

TTEC Expands India Operations with New Mohali Customer Experience Center, Adding 400 New Jobs

TTEC Expands India Operations with New Mohali Customer Experience Center, Adding 400 New Jobs

AUSTIN, Texas and MOHALI, India, May 6, 2025 /PRNewswire/ -- TTEC Holdings, Inc. (NASDAQ: TTEC), a leading global customer experience (CX) technology and services innovator, today announced the expansion of its India operations with a new customer...

JuCoin made a global impact at TOKEN2049 Dubai, advancing its ecosystem with the "Peak Experience" vision and JuChain's robust tech.

JuCoin made a global impact at TOKEN2049 Dubai, advancing its ecosystem with the "Peak Experience" vision and JuChain's robust tech.

SINGAPORE, May 6, 2025 /PRNewswire/ -- JuCoin, a global leader in cryptocurrency trading and Web3 ecosystem development, recently hosted a series of landmark strategic initiatives during TOKEN2049 Dubai (April 30 – May 1, 2025), one of the world's...

Interlace Breaks New Ground in Web3 Finance with CaaS at Token2049

Interlace Breaks New Ground in Web3 Finance with CaaS at Token2049

NEW YORK, May 6, 2025 /PRNewswire/ -- On May 1st, the global blockchain industry event Token2049 concluded successfully, marking a significant moment for Web3 and fintech innovations. Interlace, a leading Web3 fintech company, made its debut at the...

Xiao-I Corporation Expands Strategic Partnership with AIA China Through RMB 3-4 Million AI Solutions Deal

Xiao-I Corporation Expands Strategic Partnership with AIA China Through RMB 3-4 Million AI Solutions Deal

SHANGHAI, May 6, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a leading AI enterprise, announced the expansion of its partnership with AIA China, a leading insurance provider, through a one-year contract valued at RMB 3–4 million. This...

Lightweight Tech, Maximum Freedom: PGYTECH's OneGo 2 and OneGo Rope Strap Bag Empowers Urban Creators

Lightweight Tech, Maximum Freedom: PGYTECH's OneGo 2 and OneGo Rope Strap Bag Empowers Urban Creators

NEW YORK, May 6, 2025 /PRNewswire/ -- On May 6, 2025, globally renowned photography accessory brand PGYTECH proudly unveils the OneGo 2 series, featuring two innovative Urban camera backpacks: OneGo 2 and OneGo Rope Strap Bag. Both offerings combine...

True Global Ventures Doubles Down on BookitnGo as Claritas Leads Series A Round to Accelerate AI-Powered Travel Tech

True Global Ventures Doubles Down on BookitnGo as Claritas Leads Series A Round to Accelerate AI-Powered Travel Tech

PALO ALTO, Calif., May 6, 2025 /PRNewswire/ -- True Global Ventures (TGV) is proud to announce its continued and increased support for BookitnGo, participating in the company's latest Series A funding round led by Claritas Capital, a leading growth...

Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors

Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, a Northern Ireland-based research driven drug discovery...

1 ... 34 35 36 37 38 39 40 41 42 ... 2480
menu
menu